{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:14:28Z","timestamp":1788570868288,"version":"build-2803163510"},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"2","funder":[{"DOI":"10.13039\/501100001691","name":"the Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19111212"],"award-info":[{"award-number":["19111212"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JST SPRING","award":["JPMJSP2135"],"award-info":[{"award-number":["JPMJSP2135"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0150","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T22:11:10Z","timestamp":1732572670000},"page":"193-203","source":"Crossref","is-referenced-by-count":2,"title":["Clinical comparison and genetic analysis in pheochromocytoma with primary aldosteronism"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-5662","authenticated-orcid":false,"given":"Xurong","family":"Mai","sequence":"first","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-3018","authenticated-orcid":false,"given":"Mitsuhiro","family":"Kometani","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Aiga","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-9653","authenticated-orcid":false,"given":"Shigehiro","family":"Karashima","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aono","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Department of Uro-Oncology, International Medical Center Saitama Medical University, Saitama 350-1298, Japan"},{"name":"Department of Biochemistry, Keio University School of Medicine, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-1825","authenticated-orcid":false,"given":"Kazuyoshi","family":"Hosomichi","sequence":"additional","affiliation":[{"name":"Laboratory of Computational Genomics, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3079","authenticated-orcid":false,"given":"Atsushi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Clinical Genetics, Kanazawa University Hospital, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0921-158X","authenticated-orcid":false,"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University Graduate School of Medicine, Ishikawa 920-8641, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Umemura S, Arima H, Arima S, Asayama K, Dohi Y, et al. (2019) The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Lenders JWM, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366: 665\u2013675.","DOI":"10.1016\/S0140-6736(05)67139-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Anderson GH Jr, Blakeman N, Streeten DH (1994) The effect of age on prevalence of secondary forms of hypertension in 4,429 consecutively referred patients. J Hypertens 12: 609\u2013615.","DOI":"10.1097\/00004872-199405000-00015"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193\u2013202.","DOI":"10.1291\/hypres.27.193"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Al Subhi AR, Boyle V, Elston MS (2022) Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years. J Endocr Soc 6: bvac105.","DOI":"10.1210\/jendso\/bvac105"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, et al. (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99: 1915\u20131942.","DOI":"10.1210\/jc.2014-1498"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Vaidya A, Carey RM (2020) Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metab 105: 3771\u20133783.","DOI":"10.1210\/clinem\/dgaa606"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, et al. (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71: 530\u2013537.","DOI":"10.1161\/HYPERTENSIONAHA.117.10263"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol 3: 768\u2013774.","DOI":"10.1001\/jamacardio.2018.2003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Scholl UI (2022) Genetics of primary aldosteronism. Hypertension 79: 887\u2013897.","DOI":"10.1161\/HYPERTENSIONAHA.121.16498"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kamilaris CDC, Stratakis CA, Hannah-Shmouni F (2021) Molecular genetic and genomic alterations in Cushing\u2019s syndrome and primary aldosteronism. Front Endocrinol (Lausanne) 12: 632543.","DOI":"10.3389\/fendo.2021.632543"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Mao JJ, Baker JE, Rainey WE, Young WF Jr, Bancos I (2021) Concomitant pheochromocytoma and primary aldosteronism: a case series and literature review. J Endocr Soc 5: bvab107.","DOI":"10.1210\/jendso\/bvab107"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ugi S, Yonishi M, Sato D, Nakaizumi N, Horikawa O, et al. (2023) Coexistence of pheochromocytoma and primary aldosteronism due to multiple aldosterone-producing micronodules in the ipsilateral adrenal gland. Intern Med 62: 2685\u20132691.","DOI":"10.2169\/internalmedicine.1012-22"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, et al. (2014) Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol 383: 111\u2013117.","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6: 51\u201359.","DOI":"10.1016\/S2213-8587(17)30367-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Canu L, Parenti G, De Filpo G, Mannelli M (2019) Pheochromocytomas and paragangliomas as causes of endocrine hypertension. Front Endocrinol (Lausanne) 10: 333.","DOI":"10.3389\/fendo.2019.00333"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Haase M, Dringenberg T, Allelein S, Willenberg H, Schott M (2017) Excessive catecholamine secretion and the activation of the renin-angiotensin-aldosterone-system in patients with pheochromocytoma: a single center experience and overview of the literature. Horm Metab Res 49: 748\u2013754.","DOI":"10.1055\/s-0043-117179"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Yamada T, Fukuoka H, Hosokawa Y, Odake Y, Yoshida K, et al. (2020) Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports. BMC Endocr Disord 20: 140.","DOI":"10.1186\/s12902-020-00620-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, et al. (1992) Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 263: E863\u2013E869.","DOI":"10.1152\/ajpendo.1992.263.5.E863"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 M\u00fcller MWH, Todorov V, Kr\u00e4mer BK, Kurtz A (2002) Angiotensin II inhibits renin gene transcription <i>via<\/i> the protein kinase C pathway. Pflugers Arch 444: 499\u2013505.","DOI":"10.1007\/s00424-002-0835-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Gonzalez-Garcia C, Keiser HR (1990) Angiotensin II and angiotensin converting enzyme binding in human adrenal gland and pheochromocytomas. J Hypertens 8: 433\u2013441.","DOI":"10.1097\/00004872-199005000-00007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Opocher G, Rocco S, Cimolato M, Vianello B, Arnaldi G, et al. (1997) Angiotensin II receptors in cortical and medullary adrenal tumors. J Clin Endocrinol Metab 82: 865\u2013869.","DOI":"10.1210\/jc.82.3.865"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Col V, de Canni\u00e8re L, Messaoudi L, Michel L, Donckier J (1999) Heart failure induced by pheochromocytoma: laparoscopic treatment and intraoperative changes of several new cardiovascular hormones. Horm Res 51: 50\u201352.","DOI":"10.1159\/000023314"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Choi M, Scholl UI, Yue P, Bj\u00f6rklund P, Zhao B, et al. (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331: 768\u2013772.","DOI":"10.1126\/science.1198785"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, et al. (2012) Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab 97: 1311\u20131319.","DOI":"10.1210\/jc.2011-2885"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Zheng FF, Zhu LM, Nie AF, Li XY, Lin JR, et al. (2015) Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension 65: 622\u2013628.","DOI":"10.1161\/HYPERTENSIONAHA.114.03346"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Hong AR, Kim JH, Song YS, Lee KE, Seo SH, et al. (2016) Genetics of aldosterone-producing adenoma in Korean patients. PLoS One 11: e0147590.","DOI":"10.1371\/journal.pone.0147590"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Fernandes-Rosa FL, Williams TA, Riester A, Steichen O, Beuschlein F, et al. (2014) Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64: 354\u2013361.","DOI":"10.1161\/HYPERTENSIONAHA.114.03419"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Scholl UI, Goh G, St\u00f6lting G, de Oliveira RC, Choi M, et al. (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45: 1050\u20131054.","DOI":"10.1038\/ng.2695"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Galan SR, Kann PH (2013) Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol (Oxf) 78: 165\u2013175.","DOI":"10.1111\/cen.12071"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Nanba K, Baker JE, Blinder AR, Bick NR, Liu CJ, et al. (2022) Histopathology and genetic causes of primary aldosteronism in young adults. J Clin Endocrinol Metab 107: 2473\u20132482.","DOI":"10.1210\/clinem\/dgac408"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32 De Sousa K, Boulkroun S, Baron S, Nanba K, Wack M, et al. (2020) Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma. Hypertension 75: 1034\u20131044.","DOI":"10.1161\/HYPERTENSIONAHA.119.14177"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/2\/72_EJ24-0150\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:24:20Z","timestamp":1738985060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/2\/72_EJ24-0150\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0150","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0150"}}